MYCOCEL S 180 mg

Maintenance immunosuppression in renal transplant patients. Used for long-term prevention of graft rejection with reduced dosing in stable transplant recipients.

Inhibits de novo purine synthesis in lymphocytes, providing selective immunosuppression with reduced toxicity to other rapidly dividing cells.

As recommended or prescribed by a healthcare professional, nephrologist, transplant physician, or relevant specialist.